IMMUNE-MEDIATED NEUROLOGICAL DISORDER

IMMUNE-MEDIATED NEUROLOGICAL DISORDER was reported 87 times

IMMUNE-MEDIATED NEUROLOGICAL DISORDER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 74 0.0008
1 CTLA-4-directed Blocking Antibody [EPC] 18 0.0004
2 Programmed Death Ligand-1 Blocker [EPC] 5 0.0002
3 Glinide [EPC] 1 0.0001
4 Antimalarial [EPC] 1 0.0001
5 Antiprotozoal [EPC] 1 0.0001
6 Platinum-based Drug [EPC] 17 0.0001
7 Microtubule Inhibitor [EPC] 10 0.0001
8 Non-narcotic Antitussive [EPC] 1 0.0001
9 Orexin Receptor Antagonist [EPC] 1 0.0001
10 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
11 Human Immunoglobulin G [EPC] 1 0.0000
12 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2 0.0000
13 Glycopeptide Antibacterial [EPC] 1 0.0000
14 Arteriolar Vasodilator [EPC] 1 0.0000
15 Catecholamine [EPC] 1 0.0000
16 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
17 Anti-IgE [EPC] 1 0.0000
18 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
19 Prostaglandin Analog [EPC] 1 0.0000
20 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
21 Aminosalicylate [EPC] 1 0.0000
22 5-alpha Reductase Inhibitor [EPC] 1 0.0000
23 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
24 Proton Pump Inhibitor [EPC] 5 0.0000
25 Alkylating Drug [EPC] 2 0.0000
26 Tumor Necrosis Factor Blocker [EPC] 5 0.0000
27 Expectorant [EPC] 1 0.0000
28 Opioid Agonist [EPC] 1 0.0000
29 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
30 Kinase Inhibitor [EPC] 2 0.0000
31 Platelet Aggregation Inhibitor [EPC] 2 0.0000
32 Osmotic Laxative [EPC] 1 0.0000
33 beta-Adrenergic Blocker [EPC] 1 0.0000
34 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
35 Corticosteroid [EPC] 4 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
37 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
38 Benzodiazepine [EPC] 1 0.0000